The global bronchiectasis drugs market is estimated to be valued at US$ 303.8 million in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Bronchiectasis is a chronic respiratory disease characterized by the widening and inflammation of the bronchial tubes. This condition results in the build-up of mucus ... Read more
